Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), a leading international provider of consumer cannabis products, has announced three new hires joining the company’s executive leadership team this month. Ed Kremer will join as Chief Financial Officer, Camilo Lyon was named Chief Investment Officer, and Mitch Hara will be Chief Strategy Officer, a new role at the company. Mr. Kremer and Mr. Lyon will begin August 8 and Mr. Hara joined effective August 3.
The news comes as Matt Darin, who was named Curaleaf CEO in February of this year, has focused his first months of leadership on reorganizing the company for long term success, and on the heels of record-breaking second quarter earnings, the first under Darin as CEO. In May, Darin named Tyneeha Rivers the company’s first Chief People Officer, to continue to drive Curaleaf’s culture and become the destination for the highest level of talent in the industry.
Newly appointed Chief Financial Officer Ed Kremer has most recently been working in the cannabis industry and brings a wealth of experience as a public CFO and leader at companies such as Oakley, Beats by Dre, and Oliver Peoples. Neil Davidson, Curaleaf’s Interim CFO, will work closely with Mr. Kremer during the transition period.
Camilo Lyon will lead Capital Markets and Investor Relations as Curaleaf’s first Chief Investment Officer. Mr. Lyon most recently worked as a Managing Director at BTIG, where he covered the consumer and cannabis sectors. He brings over 20 years of finance experience and a wealth of knowledge and relationships to the role.
In the newly created Chief Strategy Officer Role, Mitch Hara will oversee the company’s strategy functions including mergers and acquisitions, international, and research and development. Mr. Hara brings years of experience as a seasoned strategist, operator, and dealmaker on Wall Street and in cannabis, most recently as Head of M&A and Business Development at Clever Leaves International.
Chief Executive Officer Matt Darin said, “From the first day I assumed the CEO role, I have been relentlessly focused on three key areas: leadership and culture, operational excellence and delivering quality products and brands at scale. I firmly believe that the foundation of all successful organizations is leadership and culture, and I am confident that these three hires will ensure Curaleaf’s future as the global leader in product innovation, brands, quality and safety, legislative reform efforts, CSR and of course, talent. Ed, Camilo, and Mitch all bring robust industry experience; track records of business discipline, growth and success; and smart strategic insights that will drive Curaleaf towards fulfilling our long-term goals. I’m thrilled to welcome them to the leadership team, and I’d like to thank Neil Davidson for his continued commitment and contributions to Curaleaf.”
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 22 states with 136 dispensaries, 26 cultivation sites, and employs over 5,700 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction, and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
